Pediatrix Medical Group (MD) Earnings Analysis

Pediatrix Medical Group (MD) has no confirmed upcoming earnings date. Last quarter (2026-02-19) it missed with EPS 0.5 USD vs 0.53 USD est (-5.7%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E 12.54.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MD next report earnings?

No confirmed upcoming earnings date is currently scheduled for MD. This page updates as the calendar is published.

MD earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-190.5 USD0.53 USD-5.7%Miss
2025-11-030.67 USD0.46 USD+45.7%Beat
2025-02-200.51 USD0.37 USD+37.8%Beat
2024-11-010.44 USD0.37 USD+18.9%Beat

Beat rate: 3/4 (75%) over reported quarters with consensus data.

MD valuation and analyst view

Trailing P/E12.54
Trailing EPS2.097 USD
Price / book2.44
Dividend yield0.00%
Market cap2.11B
Analyst consensusHold (14 buy / 17 hold / 2 sell)
Avg price target25.67 USD

Related research pages

Frequently asked questions

When is Pediatrix Medical Group (MD)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for MD. This page updates as the calendar is published.

Did MD beat earnings last quarter?

In its 2026-02-19 report, MD posted EPS of 0.5 USD versus a 0.53 USD estimate — a miss of 5.7%.

What is MD's earnings track record?

Over the last 4 reported quarters with consensus data, MD beat estimates 3 times (75%).

What is MD's current P/E ratio and EPS?

MD trades at a trailing P/E of 12.54 on trailing EPS of 2.0971772494733676 USD.

What do analysts rate MD?

Analyst consensus is "Hold" across 33 ratings (0 strong buy, 14 buy, 17 hold, 2 sell, 0 strong sell). Average 12-month price target: 25.67 USD.